Published in J Med Microbiol on January 19, 2012
Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes. Cell Host Microbe (2015) 1.48
Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol (2013) 0.98
Vaccines in the treatment of invasive candidiasis. Virulence (2015) 0.86
Vaccine immunity against fungal infections. Curr Opin Immunol (2014) 0.82
Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice. Hum Vaccin Immunother (2014) 0.82
Studies of Immune Responses in Candida vaginitis. Pathogens (2015) 0.81
A unique biofilm in human deep mycoses: fungal amyloid is bound by host serum amyloid P component. NPJ Biofilms Microbiomes (2015) 0.81
Development of Protective Inflammation and Cell-Mediated Immunity against Cryptococcus neoformans after Exposure to Hyphal Mutants. MBio (2015) 0.79
The antifungal pipeline: a reality check. Nat Rev Drug Discov (2017) 0.77
New insights on the development of fungal vaccines: from immunity to recent challenges. Mem Inst Oswaldo Cruz (2015) 0.75
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Front Microbiol (2017) 0.75
Beta-glucan contamination of pharmaceutical products: How much should we accept? Cancer Immunol Immunother (2016) 0.75
A Convergent Synthesis of 6-O-Branched β-Glucan Oligosaccharides. European J Org Chem (2015) 0.75
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol (2007) 4.54
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis (2003) 4.29
Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol (2007) 3.43
Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog (2009) 3.05
Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem (2004) 2.77
Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest (2011) 2.66
A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med (2005) 2.35
Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol Microbiol (1995) 2.08
The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun (2008) 1.77
Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med (1999) 1.67
Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol (2006) 1.58
Saccharomyces as a vaccine against systemic aspergillosis: 'the friend of man' a friend again? J Med Microbiol (2011) 1.52
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood (2003) 1.45
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun (2005) 1.35
Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect (2002) 1.30
A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun (2009) 1.23
Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A (2008) 1.22
Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis (1993) 1.21
Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.19
Fungal vaccines: real progress from real challenges. Lancet Infect Dis (2008) 1.16
Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect Immun (1971) 1.15
A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine (2009) 1.09
Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun (2007) 1.09
Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun (2010) 1.09
Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J Immunol (1985) 1.07
Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J Infect Dis (1978) 1.04
The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol (1975) 1.03
Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun (2011) 1.03
The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. J Immunol (2002) 1.02
Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02
Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen. Infect Immun (1994) 0.99
Developing a vaccine against aspergillosis. Med Mycol (2010) 0.99
Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun (2006) 0.98
Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun (2008) 0.98
Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol (2011) 0.92
Vaccines for invasive fungal infections. F1000 Med Rep (2011) 0.92
Prospects of vaccines for invasive aspergillosis. Med Mycol (2005) 0.90
Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol (2005) 0.90
Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine (2009) 0.89
Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection. Vaccine (2011) 0.88
Prospects for development of a vaccine to prevent and control vaginal candidiasis. Curr Infect Dis Rep (2011) 0.87
Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis). Ann N Y Acad Sci (2007) 0.87
Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes Immun (2005) 0.85
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation. Blood Cells Mol Dis (2004) 0.85
Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Vaccine (2005) 0.84
Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann N Y Acad Sci (2007) 0.84
An alternative renewable source of squalene for use in emulsion adjuvants. Vaccine (2011) 0.84
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine (2011) 0.83
Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis. PLoS One (2011) 0.82
Vaccine progress. Med Mycol (2009) 0.82
Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats. Can J Microbiol (2011) 0.82
Dendritic cell-based vaccine against coccidioides infection. Ann N Y Acad Sci (2007) 0.80
Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis. Infect Immun (2011) 0.80
Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol (2011) 0.77
Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods. Ann N Y Acad Sci (2007) 0.77